Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Interventional Treatment and Clinical Research Center of Henan Province, Zhengzhou, China.
J Cardiothorac Surg. 2021 Mar 20;16(1):39. doi: 10.1186/s13019-021-01418-w.
To evaluate the efficacy of percutaneous stent placement in the treatment of superior vena cava syndrome caused by malignant tumors.
We retrospectively analyzed the clinical data of 32 patients with superior vena cava syndrome who underwent percutaneous endovascular stent treatment in our department from 2015 to 2019 due to malignant tumors and summarized the patient's sex, age, tumor type, endovascular treatment plan, complications and postoperative follow-up.
All patients successfully underwent percutaneous intraluminal stent placement with digital subtraction angiography (DSA). Thirty-seven endovascular stents were implanted in 32 patients, including 21 Eluminexx stents, 12 Wallstent stents and 4 covered stents. The technical success rate was 100%, and there were no serious surgery-related complications. The remission rate of clinical symptoms was 53.1% (17/32) at 24 h and 84.4% (27/32) at 48 h. After 48 h, the symptoms of the remaining patients were slowly relieved, and the symptom relief rate was 100% at 7 days. The follow-up period was 1.5-24 months, with an average follow-up period of 6.5 months. During the follow-up, 3 patients had restenosis and 1 patient had secondary thrombosis in the stent. Their symptoms were relieved after the second treatment.
For superior vena cava syndrome caused by malignant tumors, percutaneous endoluminal stent therapy can quickly and effectively relieve the clinical symptoms of patients, and the incidence of complications is low.
评估经皮腔内支架置入术治疗恶性肿瘤引起的上腔静脉综合征的疗效。
回顾性分析 2015 年至 2019 年我科 32 例因恶性肿瘤行经皮腔内血管支架置入术治疗的上腔静脉综合征患者的临床资料，总结患者的性别、年龄、肿瘤类型、腔内治疗方案、并发症及术后随访情况。
所有患者均成功完成数字减影血管造影（DSA）引导下经腔内支架置入术。32 例患者共植入 37 枚血管内支架，其中 Eluminexx 支架 21 枚，Wallstent 支架 12 枚，覆膜支架 4 枚。技术成功率为 100%，无严重与手术相关的并发症。24 h 时临床症状缓解率为 53.1%（17/32），48 h 时为 84.4%（27/32）。48 h 后，其余患者症状逐渐缓解，7 d 时症状缓解率达 100%。随访时间为 1.5~24 个月，平均随访 6.5 个月。随访期间 3 例患者出现再狭窄，1 例支架内再发血栓，再次治疗后症状缓解。
对于恶性肿瘤引起的上腔静脉综合征，经皮腔内支架置入术治疗可快速有效地缓解患者的临床症状，并发症发生率低。
